1. Welsh MJ, Smith AE. Cystic fibrosis. Sci Am 1995, 273(6): 52-59.

2. Busch R. On the history of cystic fibrosis. Acta Univ Carol [Med] (Praha) 1990, 36(1-4): 13-15.

3. Fanconi G, Uehlinger E, Knauer C. Das Coeliakiesyndrom bei angeborener zystischer Pankreasfibromatose und Bronchiektasen. Wien Med Wochenschr 1936, 86: 753-756.

4. Anderson DH. Cystic fibrosis of the pancreas and its relation to celiac disease: clinical and pathological study. Am J Dis Child 1938, 56: 344-399.

5. Farber S. Some organic digestive disturbances in early life. Michigan Med Soc 1945, 44: 587-594.

6. Di Sant´ Agnese PA, Darling RC, Perera GA, Shea E. Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas, it’s clinical significance and relationship to the disease. Pediatrics 1953, 12: 549-563.

7. Gibson LE, Cooke RE. A test for concentration of electrolytes in cystic fibrosis using pilocarpine by electrophoresis. Pediatrics 1959, 23: 549-563.

8. Riordan JR, Rommens JM, Kerem BS et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245: 1066-1072.

9. Tsui LC, Buchwald M, Barker D et al.. Cystic fibrosis locus defined by a genetically linked polymorphic marker. Science 1985, 230: 1054-1057.

10. The Cystic Fibrosis Genetic Analysis Consortium. Cystic Fibrosis Mutation Data Base. 13.07.2003,.

11. Merlo CA, Boyle MP. Modifier genes in cystic fibrosis lung disease. J Lab Clin Med 2003, 141: 237-241.

12. Orenstein DM, Winnie GB, Altman H. Cystic fibrosis: A 2002 update. J Pediatr 2002, 140: 156-164.

13. Brennan AL, Geddes DM. Cystic fibrosis. Curr Opin Infect Dis 2002, 15: 175-182.

14. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002, 15(2): 194-222.

15. Hoiby N, Johansen HK, Moser C, Song Z, Ciofu O, Kharazmi A. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microb Infect 2001, 3: 23-35.

16. Oliver A, Cantón R, Campo P, Baquero F, Blázquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000, 288: 1251-1253.

17. Davies JC. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. Pediatr Respir Rev 2002, 3: 128-134.

18. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997, 88: 553-560.

19. Davies J, Dewar A, Bush A, Pitt T, Gruenert D, Geddes DM, Alton EW. Reduction in the adherence of Pseudomonas aeruginosa to native cystic fibrosis respiratory epithelium with anti-asialo-GM1 antibody and neuraminidase inhibition. Eur Respir J 1999, 13: 565-570.

20. Döring G, Conway SP, Heijermann HG, Hodson ME, Hoiby N, Smyth A, Touw DJ. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000, 16: 749-767.

21. Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, Ramsey BW. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 2001, 183: 444-452.

22. Ratjen F. Early interventions in CF. Pediatr Pulmonol 2004, Suppl 26: 88-90.

23. Rö mling U, Fiedler B, Boßhammer J, Grothues D, Greipel J, von der Hardt H, Tümmler B. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J Infect Dis 1994, 170: 1616-1621.

24. Costerton JW. Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. Trends Microbiol 2001, 9(2): 50-52.

25. Khan TZ, Wagener JS, Bost T. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995, 151: 1075-1082.

26. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Gutierrez JP, Hull J, Olinsky A, Phelan EM, Robertson CF, Phelan PD. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997, 156: 1197-1204.

27. Dakin CJ, Numa AH, Wang HE, Morton JR, Vertzyas CC, Henry RL. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 2002, 165: 904-910.

28. Konstan MW, Hilliard KA, Norvell TM, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing inflammation. Am J Respir Crit Care Med 1994, 150: 448-454.

29. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Olinsky A, Phelan PD. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory tract pathogens in infants with cystic fibrosis. Paediatr Pulmonol 1996, 21: 267-275.

30. Baughman RP, Keeton DA, Perez C, Wilmott RW. Use of bronchoalveolar lavage semiquantitative cultures in cystic fibrosis Am J Respir Crit Care Med 1997, 156: 286-291.

31. Ramsey BW, Wentz KR, Smith AL, Richardson M, Williams-Warren J, Hedges DL, Gibson R, Redding GJ, Lent K, Harris K. Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. Am Rev Respir Dis 1991, 144: 331-337.

32. Rosenfeld M, Emerson J, Accurso F, Armstrong D, Castile R, Grimwood K, Hiatt P, McCoy K, McNamara S, Ramsey B. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999, 28: 321-328.

33. Fyfe JAM, Harris G, Govan JRW. Revised pyocin typing method for Pseudomonas aeruginosa. J Clin Microbiol 1984, 20(1): 47-50.

34. Pitt TL. Epidemiological typing of Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 1988, 7(2): 238-247.

35. The International Pseudomonas aeruginosa Typing Study Group. A multicenter comparison of methods for typing strains of Pseudomonas aeruginosa predominantly from patients with cystic fibrosis. J Infect Dis 1994, 169: 134-142.

36. Ojeniyi B. Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey. APMIS 1994, 102 (Suppl 46): 1-44.

37. Bergmans D, Bonten M, van Tiel F, Gaillard C, London N, van der Geest S, de Leeuw P, Stobberingh E. Value of phenotyping methods as an initial screening of Pseudomonas aeruginosa in epidemiologic studies. Infection 1997, 25(6): 350-354.

38. Ogle JW, Janda JM, Woods DE, Vasil ML. Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa. J Infect Dis 1987, 155(1): 119-126.

39. Fegan M, Francis P, Hayward AC, Fuerst JA. Heterogeneity, persistence, and distribution of Pseudomonas aeruginosa genotypes in cystic fibrosis patients. J Clin Microbiol 1991, 29(10): 2151-2157.

40. Bennekov T, Colding H, Ojeniyi B, Bentzon MW, Hoiby N. Comparison of ribotyping and genome fingerprinting of Pseudomonas aeruginosa isolates from cystic fibrosis patients. J Clin Microbiol 1996, 34(1): 202-204.

41. Bingen E, Bonacorsi S, Rohrlich P, Duval M, Lhopital S, Brahimi N, Vilmer E, Goering RV. Molecular epidemiology provides evidence of genotypic heterogeneity of multidrug-resistant Pseudomonas aeruginosa serotype O:12 outbreak isolates from a pediatric hospital. J Clin Microbiol 1996, 34(12): 3226-3229.

42. Renders N, van Belkum A, Barth A, Goessens W, Mouton J, Verbrugh H. Typing of Pseudomonas aeruginosa strains from patients with cystic fibrosis: phenotyping versus genotyping. Clin Microbiol Infect 1996, 1(4): 261-265.

43. Hernandez J, Ferrus MA, Hernandez M, Owen RJ. Arbitrary primed PCR fingerprinting and serotyping of clinical Pseudomonas aeruginosa strains. FEMS Immunol Med Microbiol 1997, 17: 37-47.

44. Mereghetti L, Marquet-van der Mee N, Loulergue J, Rolland JC, Audurier A. Pseudomonas aeruginosa from cystic fibrosis patients: a study using whole cell RAPD and antibiotic susceptibility. Path Biol 1998, 46(5): 319-324.

45. Moore JE, Elborn JS, Murphy PG, Gilligan PH, Fanning S, Hogg G. Towards "molecular Esperanto" or the tower of Babel? (The need for harmonization of techniques for genotyping clinical isolates of Pseudomonas aeruginosa isolated from patients with cystic fibrosis). J Clin Microbiol 2003, 41(11): 5347-5348.

46. Buchholz P, Richter M, Fiedler G, Halle E. Epidemiological fingerprinting of multi-resistant strains of Pseudomonas aeruginosa isolated from patients of intensive care units of the Charité Hospital, Berlin. Med Microbiol Lett 1995, 4: 7-13.

47. Grundmann H, Schneider C, Hartung D, Daschner FD, Pitt TL. Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa. J Clin Microbiol 1995, 33: 528-534.

48. Renders N, Römling U, Verbrugh H, van Belkum A. Comparative typing of Pseudomonas aeruginosa by random amplified polymorphic DNA or pulsed-field gel electrophoresis of DNA macrorestriction fragments. J Clin Microbiol 1996, 34: 3190-3195.

49. Struelens MJ, Schwam V, Deplano A, Baran D. Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients. J Clin Microbiol 1993, 31: 2320-2326.

50. Talon D, Cailleaux V, Thouverez M, Michel-Briand Y. Discriminatory power and usefulness of pulsed-field gel electrophoresis in epidemiological studies of Pseudomonas aeruginosa. J Hops Infect 1996, 32: 135-145.

51. Döring G, Jansen S, Noll H, Grupp H, Frank F, Botzenhart K, Magdorf K, Wahn U. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward. Pediatr Pulmonol 1996, 21: 90-100.

52. Grothues D, Tümmler B. New approaches in genome analysis by pulsed-field gel electrophoresis: application to the analysis of Pseudomonas species. Mol Microbiol 1991, 5: 2763-2776.

53. Mahenthiralingam E, Campbell ME, Foster J, Lam JS, Speert DP. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J Clin Microbiol 1996, 34: 1129-1135.

54. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Pershing DA, Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33: 2233-2239.

55. Speert DP, Campbell E, Henry DA, Milner R, Taha F, Gravelle A, Davidson AGF, Wong LTK, Mahenthiralingam E. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. Am J Respir Crit Care Med 2002, 166: 988-993.

56. Armstrong DS, Nixon GM, Carzino R, Bigham A, Carlin JB, Robins-Browne RM, Grimwood K. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med 2002, 166: 983-987.

57. Pitt TL, Sparrow M, Warner M, Stefanidou M. Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents. Thorax 2003, 58: 794-796.

58. Scott FW, Pitt TL. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J Med Microbiol 2004, 53(7): 609-615.

59. Elaichouni A, Verschraegen G, Claeys G, Devleeschouwer M, Godard C, Vaneechoutte M. Pseudomonas aeruginosa serotype O12 outbreak studied by arbitrary primer PCR. J Clin Microbiol 1994, 32: 666-671.

60. Grundmann HJ, Gräser Y, Schönian G, Daschner FD. Randomly primed polymerase chain reaction yields comparable results to restriction fragment analysis in typing of Pseudomonas aeruginosa. Med Microbiol Lett 1994, 3: 42-48.

61. Hoogkamp-Korstanje JAA, Meis JFGM, Kissing J, van der Laag J, Melchers WJG. Risk of cross-colonization and infection by Pseudomonas aeruginosa in a holiday camp for cystic fibrosis patients. J Clin Microbiol 1995, 33: 572-575.

62. Kersulyte D, Struelens MJ, Deplano A, Berg DE. Comparison of arbitrarily primed PCR and macrorestriction (pulsed-field gel electrophoresis) typing of Pseudomonas aeruginosa strains form cystic fibrosis patients. J Clin Microbiol 1995, 33: 2216-2219.

63. Ratjen F, Rietschel E, Griese M, Ballmann M, Kleinau I, Döring G, Reinhardt D, Paul K for the bronchoalveolar lavage for the evaluation of ant-inflammatory treatment (BEAT) study group. Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function. Eur Respir J 2000, 15: 141-145.

64. Paul K, Rietschel E, Ballmann M, Griese M, Worlitzsch D, Shute J, Chen C, Schink T, Döring G, van Koningsbruggen S, Wahn U, Ratjen F. Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis. Am J Respir Crit Care Med 2004, 169: 719-725.

65 . Claros MC, Citron DM, Hunt-Gerardo S, Goldstein EJC, Schönian G, Montag T, Hampelo B, Dofloff AC. Characterization of indole-negativ Bacteroides fragilis group species with use of polymerase chain reaction fingerprinting and resistance profiles. Clin Infect Dis 1996, 23 (Suppl 1): 66-72.

66 . Gräser Y, Klare I, Halle E, Gantenberg R, Buchholz P, Jacobi HD, Presber W, Schönian G. Epidemiological study of an Acinetobacter baumannii outbreak by using polymerase chain reaction fingerprinting. J Clin Microbiol 1993, 31 2: 417-2420.

67 . Schönian G, Schweynoch C, Zlateva K, Oskam L, Kroon N, Gräser Y, Presber W. Identification and determination of the relationships of species and strains within the genus Leishmania using single primers in the polymerase chain reaction. Mol Biochem Parasitol 1996, 77: 19-29.

68 . Thanos M, Schönian G, Meyer W, Schweynoch C, Gräser Y Mitchell TG, Presber W, Tietz HJ. Rapid identification of Candida species by DNA fingerprinting with PCR. J Clin Microbiol 1996, 34 6: 15-621.

69 . Gräser Y, El Fari M, Presber W, Sterry W, Tietz HJ. Identification of common dermatophytes (Trichophyton, Microsporum, Epidermophyton) using polymerase chain reactions. Brit J Dermatol 1998, 138: 576-582.

70 . De Boeck K, Alifier M, Vandeputte S. Sputum inducing in young cystic fibrosis patients. Eur Respir J 2000, 16 9: 1-94.

71 . Reinhardt N, Chen CIU, Loppow D, Schink T, Kleinau I, Jörres RA, Wahn U, Magnussen H, Paul KP. Cellular profiles of induced sputum in children with stable cystic fibrosis: comparison with BAL. Eur Respir J 2003, 224: 97-502.

72 . Schwartz DC, Cantor CR. Separation of yeast chromosome-sized DNAs by pulsed-field gradient gel electrophoresis. Cell 1984, 37(1): 67-75.

73 . Carle GF, Olson MV. An electrophoretic karyotype for yeast. Proc Natl Acad Sci USA 1985, 82(11): 3756-3760.

74 . Williams JGK, Kubelik AR, Livak KJ, Rafalski JA, Tingey SV. DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res 1990, 18: 6531-6535.

75 . Welsh J, McClelland M. Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res1990, 18 7: 213-7218.

76 . McCallum SJ, Corkill J, Gallagher M, Ledson MJ, Hart CA, Walshaw MJ. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonized by P. aeruginosa. Lancet 2001, 358: 558-560.

77 . Edenborough FP, Stone HR, Kelly SJ, Zadik P, Doherty CJ, Govan JRW. Genotyping of Pseudomonas aeruginosa in cystic fibrosis suggests need for segregation. J Cystic Fibrosis 2004, 3: 37-44.